SCHEMBL8516573

SCHEMBL8516573

CS(=O)(=O)Nc1cccc(Nc2cc(-c3ccc(F)cc3)ncn2)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 8/20 0.69
CYP3A4 P08684 8/20 0.69
CYP2C19 P33261 6/20 0.69
CYP2D6 P10635 5/20 0.69
CLK4 Q9HAZ1 4/20 0.69
CYP2C9 P11712 4/20 0.69
USP2 O75604 3/20 0.69
TSHR P16473 3/20 0.69
CDK9 P50750 4/20 0.64
CCNT1 O60563 3/20 0.64
MAP4K4 O95819 1/20 0.64
CDK1 P06493 1/20 0.64
CDK4 P11802 1/20 0.64
CCNB1 P14635 1/20 0.64
CCND1 P24385 1/20 0.64
ABL2 P42684 1/20 0.64
GSK3A P49840 1/20 0.64
CDK7 P50613 1/20 0.64
CCNH P51946 1/20 0.64
MNAT1 P51948 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8513621 0.89 CYP1A2 (0.74) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL8516577 0.89 CYP1A2 (0.86) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL8515489 0.86 CCNT1 (0.68) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL8514297 0.82 CDK9 (0.72) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL4109231 0.82 CCNT1 (0.77) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL8515965 0.82 CYP1A2 (0.70) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL8516163 0.82 CDK9 (0.81) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL8515978 0.80 CDK9 (0.66) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL8515866 0.80 CYP3A4 (0.70) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL8514144 0.79 CYP1A2 (0.69) CYP1A2CYP3A4CYP2C19CYP2D6CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137166-B1 4, 6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES INGENIUM PHARMACEUTICALS GMBH (DE) 2012-05-30 EP claimed